CRAT Antikörper (AA 445-544)
(1 reference)-
- Target Alle CRAT Antikörper anzeigen
- CRAT (Carnitine O-Acetyltransferase (CRAT))
-
Bindungsspezifität
- AA 445-544
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CRAT Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant CRAT.
- Sequenz
- AIEDLVSMPD IFMDTSYAIA MHFHLSTSQV PAKTDCVMFF GPVVPDGYGV CYNPMEAHIN FSLSAYNSCA ETNAARLAHY LEKALLDMRA LLQSHPRAKL
- Kreuzreaktivität
- Human, Ratte
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- CRAT (NP_659006, 445 a.a. ~ 544 a.a) partial recombinant protein with GST tag.
-
anti-Carnitine O-Acetyltransferase (CRAT) (AA 1-430) antibody
CRAT Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Carnitine O-Acetyltransferase (CRAT) (AA 363-626) antibodyCRAT Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Carnitine O-Acetyltransferase (CRAT) (AA 181-346) antibodyCRAT Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Carnitine O-Acetyltransferase (CRAT) (AA 55-256) antibodyCRAT Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Carnitine O-Acetyltransferase (CRAT) (AA 66-96), (N-Term) antibodyCRAT Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB19231 unconjugated
anti-Carnitine O-Acetyltransferase (CRAT) (N-Term) antibodyCRAT Reaktivität: Human, Maus, Ratte WB, IHC, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Carnitine O-Acetyltransferase (CRAT) (AA 357-626) antibodyCRAT Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Carnitine O-Acetyltransferase (CRAT) (AA 301-400) antibodyCRAT Reaktivität: Maus WB, ELISA, ICC, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Carnitine O-Acetyltransferase (CRAT) (AA 22-71) antibodyCRAT Reaktivität: Human WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 50 % glycerol
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
: "Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. ..." in: Circulation, Vol. 124, Issue 24, pp. 2735-45, (2011) (PubMed).
-
: "Pathogenic cycle between the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine and the leukocyte-derived hemoprotein myeloperoxidase. ..." in: Circulation, Vol. 124, Issue 24, pp. 2735-45, (2011) (PubMed).
-
- Target
- CRAT (Carnitine O-Acetyltransferase (CRAT))
- Andere Bezeichnung
- CRAT (CRAT Produkte)
- Synonyme
- CAT1 antikoerper, AW107812 antikoerper, CARAT antikoerper, CAT antikoerper, Carnitine acetylase antikoerper, CrAT antikoerper, hm:zeh0248 antikoerper, zgc:92317 antikoerper, carnitine O-acetyltransferase antikoerper, carnitine acetyltransferase antikoerper, Carnitine acetyltransferase antikoerper, Carnitine acetyltransferase, putative antikoerper, carnitine O-acetyltransferase a antikoerper, CRAT antikoerper, Crat antikoerper, CNA05200 antikoerper, CNL05760 antikoerper, CC1G_06292 antikoerper, PAS_chr3_0761 antikoerper, CGB_A5470W antikoerper, CGB_D1240C antikoerper, crata antikoerper
- Hintergrund
-
Full Gene Name: carnitine acetyltransferase
Synonyms: CAT1 - Gen-ID
- 1384
- NCBI Accession
- NM_144782
- Pathways
- Monocarboxylic Acid Catabolic Process
-
